Overview

Arrowhead Pharmaceuticals, Inc. is a biotechnology company focused on developing RNA interference (RNAi) therapeutics for the treatment of intractable diseases by silencing the genes that cause them. The company's proprietary Targeted RNAi Molecule (TRiM) platform is designed to enable tissue-specific delivery of RNAi therapeutics.

Therapeutic areas

CardiovascularMetabolicPulmonaryHepaticOncological

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Arrowhead Pharmaceuticals, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Arrowhead Pharmaceuticals, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.